首页 | 本学科首页   官方微博 | 高级检索  
     

腹腔免疫化疗治疗胃癌术后癌性腹水近期疗效
引用本文:朱金水,陈尼维,陈维雄. 腹腔免疫化疗治疗胃癌术后癌性腹水近期疗效[J]. 肿瘤, 2000, 20(3): 216-217
作者姓名:朱金水  陈尼维  陈维雄
作者单位:
摘    要:目的 腹腔免疫化疗抗胃癌术后生腹水近期临床疗效及有关机理。方法 40例胃癌术后癌性腹水患者采用腹腔注射卡铁和肿瘤坏死因子α治疗,B超测定患者治疗前后腹水消褪率。结果 腹腔免疫化疗抗胃癌术后癌性腹水患者一疗程有效率73.5%,且该治疗显著降低外周血中消化道癌相关抗原(CCA)和sIL-2R含量;其褪腹水有效率高于单纯腹腔化疗和静脉化疗组。结论 卡铂和肿瘤坏死因子α具有协同抗癌作用,两者合用是治疗患者

关 键 词:胃肿瘤 腹腔免疫化疗 癌性腹水

THEEFFECTS OF INTRAPERITONEAL IMMUNOCHEMOTHERAPY OF POSTOPERATIVE GASTRIC CANCER ASCITES
ZHU Jinshui,CHEN Niwei,CHEN Weixiong et al. THEEFFECTS OF INTRAPERITONEAL IMMUNOCHEMOTHERAPY OF POSTOPERATIVE GASTRIC CANCER ASCITES[J]. Tumor, 2000, 20(3): 216-217
Authors:ZHU Jinshui  CHEN Niwei  CHEN Weixiong et al
Affiliation:ZHU Jinshui,CHEN Niwei,CHEN Weixiong et al. Department of Gastroenterology,Shanghai Sixth People's Hospital
Abstract:Objective To observe the short term effects of intraperitoneal immunochemotherapy of postoperative gastric cancer ascites.Methods 40 cases of postoperative gastric cancer ascites were treated with intraperitoneal injection of cisplatin plus tumor necrosis factor.The levels of ascites were determined by B ultrasonograph before and after the treatment.Results The short term effective rate of intraperitoneal immunochemotherapy on postoperative ascites was 735 %.The CCA and soluble interleukin receptor(sIL2R) of cases with this treatment were markedly decreased in peripheral blood.Conclusion The intraperitoneal immunochemotherapy was a simple,safe and effective method of treatment for postoperative gastric cancer ascites.
Keywords:Stomach neoplasms  Tumor necrosis factor/therapy  Peritoneal  Drug therapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号